Text Size: A+| A-| A   |   Text Only Site   |   Accessibility
Evidence Based Reports
Updated 11/12/2009
Updated 11/12/2009
/OHPPR/HRC/docs/HRC.Reports/HRC_QRMA.pdfPosted 7/10/09:  Draft Report for Newer Diabetes Medication
 
Recently Posted: Thiazolidinediones or TZD
DERP Reports and Key Questions
 
 
 HRC Report
 Executive Summary
Alzheimer’s Drugs or ALZ  
Angiotensin-Converting Enzyme Inhibitors or ACEIs  
Angiotensin II Receptor Antagonists or AIIRA
Antidepressants         1/09   
Antiemetics or NAE
 
Antiplatelet or AP
Attention Deficit Hyperactivity Disorder or ADHD  
Asthma: Quick Relief meds          11/09   
Atypical Antipsychotics  
Autism or ASD  
Beta 2 Agonists or B2  
Beta Blocker or BB
Calcium Channel Blockers or CCB
Combination Products for Type 2 DM & Hyperlipidemia or FDCP
Constipation Drugs  
Diabetes, Newer Drugs for  
Hormone Replacement Therapy - HRT
Inhaled Corticosteroid or ICS
Long-acting Analgesics for Non-cancer Pain or OPIOID
Multiple Sclerosis or MS
 
Newer Antiplatelet or AP  
Neuropathic Pain  
Non-steroidal Anti-inflammatory Drugs or NSAIDS
Obesity, Surgical  
Obesity, Medical  
Oral Hypoglycemics or OH
Over Active Bladder or OAB
Peginterferons for Hepatitis C  
Proton Pump Inhibitor or PPI
Skeletal Muscle Relaxers or SMR
STATIN
Targeted Immune Modulators or TIM
Thiazolidinediones or TZD
TRIPTAN
 


 

 
Page updated: November 18, 2009

Click here to go to the Oregon Dept. of Veterans' Affairs outreach contact form

Get Adobe Acrobat ReaderAdobe Reader is required to view PDF files. Click the "Get Adobe Reader" image to get a free download of the reader from Adobe.